Kinfo
Baird Medical Investment Holdings Inc. logo

Baird Medical Investment Holdings Inc.

BDMDNASDAQHealthcare·US · USD
$1.18
+0.01 (+0.85%)
Prices as of August 12, 2026 · market closed

Price

Key statistics

Valuation
Market cap37.74M USD
Enterprise value54.87M USD
Trailing P/E3.16
Forward P/E0.00
PEG ratio0.00
Price / sales1.67
Price / book0.77
Profitability
Gross margin0.00%
Operating margin-104.14%
Profit margin-121.04%
Return on assets-21.70%
Return on equity-77.60%
Income (TTM)
Revenue22.54M USD
Gross profit18.88M USD
EBITDA-24.53M USD
Net income-27.28M USD
Diluted EPS-$0.98
Rev. growth (YoY)-39.00%
Balance sheet
Total cash418.87K USD
Total debt19.39M USD
Debt / equity62.10
Current ratio1.70
Book value / share$1.52
Cash flow (TTM)
Operating cash flow-1.34M USD
Levered free cash flow7.83M USD
Shares & price
Shares outstanding30.75M
Float5.19M
Held by institutions0.87%
Beta-1.17
50-day MA$1.14
200-day MA$1.48
52-week high$3.75
52-week low$0.76
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-05-080.110.13+18.18%2026-03-190.160.17+6.25%2026-03-06-0.220.76+445.45%
About Baird Medical Investment Holdings Inc.

Baird Medical Investment Holdings Limited is a medical devices company specializing in microwave ablation technology for minimally invasive tumor treatment. The company develops and manufactures microwave ablation apparatus, needles, and related medical devices used to treat benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, breast lumps, and bone lesions. Operating primarily in the People's Republic of China, Baird Medical positions its microwave ablation systems as safer alternatives to traditional surgical approaches, offering patients faster recovery times and lower complication rates. The company's products are FDA 510(k)-certified and have been deployed across hospitals and clinics internationally. Baird Medical distributes its microwave ablation devices and consumables through third-party distributors and maintains a focus on expanding its presence in minimally invasive medical interventions. The company also pursues research and development initiatives in surgical robotics and intelligent diagnostic systems to complement its core medical device business.

Sector
Healthcare
Industry
Medical Devices
CEO
Ms. Haimei Wu
Employees
146
Headquarters
Guangzhou, China

Frequently asked questions about Baird Medical Investment Holdings Inc.